Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Moehler

Showing results (41-50 of 218) with videos related to

Pageof 22
Sort By:
Journal of Cancer Research and Clinical Oncology|April 7, 2011
Expression of chemokine receptor CCR5 correlates with the presence of hepatic molecular metastases in K-ras positive human colorectal cancerCarl C Schimanski, Markus Moehler, Ines Gockel, et al.
Journal of Cancer Research and Clinical Oncology|January 9, 2021
Any progress in informed consenting for cancer treatment? Results from a cross sectional analysis at a comprehensive cancer centerMarie-Kristin Schwaegermann, Melanie Schranz, Markus Moehler, et al.
Onkologie|December 17, 2008
[Surgical and perioperative therapy of liver metastases]Hans Jürgen Schlitt, Dirk Arnold, Wolfram T Knoefel, et al.
International Journal of Cancer|December 30, 2009
Analysis of anti-proliferative and chemosensitizing effects of sunitinib on human esophagogastric cancer cells: Synergistic interaction with vandetanib via inhibition of multi-receptor tyrosine kinase pathwaysOrestis Lyros, Annett Mueller, Florian Heidel, et al.
World Journal of Gastroenterology|May 7, 2009
High miR-196a levels promote the oncogenic phenotype of colorectal cancer cellsCarl Christoph Schimanski, Kirsten Frerichs, Fareed Rahman, et al.
International Journal of Oncology|May 18, 2011
SNP rs1801157 significantly correlates with distant metastasis in CXCL12 expressing esophagogastric cancerCarl C Schimanski, Mareike Jordan, Friederike Schlaegel, et al.
Future Oncology (London, England)|December 2, 2020
MAHOGANY: margetuximab combination in HER2+ unresectable/metastatic gastric/gastroesophageal junction adenocarcinomaDaniel Vt Catenacci, Minori Rosales, Hyun Cheol Chung, et al.
Zeitschrift Fur Gastroenterologie|April 12, 2018
[ASCO- and ESMO-update 2017 - highlights of the 53. meeting of the American Society of Clinical Oncology/ASCO 2017 and European Society for Medical Oncology/ESMO congress 2017]Thomas J Ettrich, Matthias Ebert, Sylvie Lorenzen, et al.
World Journal of Gastroenterology|July 19, 2008
VEGF-D expression correlates with colorectal cancer aggressiveness and is downregulated by cetuximabMarkus Moehler, Christian Frings, Annett Mueller, et al.
Targeted Oncology|September 20, 2019
Immune Checkpoint Inhibitors as Switch or Continuation Maintenance Therapy in Solid Tumors: Rationale and Current StatePetros Grivas, Bradley J Monk, Daniel Petrylak, et al.
Pageof 22

Showing results (41-50 of 218) with videos related to

Sort By:
Pageof 22
Journal of Cancer Research and Clinical Oncology|April 7, 2011
Expression of chemokine receptor CCR5 correlates with the presence of hepatic molecular metastases in K-ras positive human colorectal cancerCarl C Schimanski, Markus Moehler, Ines Gockel, et al.
Journal of Cancer Research and Clinical Oncology|January 9, 2021
Any progress in informed consenting for cancer treatment? Results from a cross sectional analysis at a comprehensive cancer centerMarie-Kristin Schwaegermann, Melanie Schranz, Markus Moehler, et al.
Onkologie|December 17, 2008
[Surgical and perioperative therapy of liver metastases]Hans Jürgen Schlitt, Dirk Arnold, Wolfram T Knoefel, et al.
International Journal of Cancer|December 30, 2009
Analysis of anti-proliferative and chemosensitizing effects of sunitinib on human esophagogastric cancer cells: Synergistic interaction with vandetanib via inhibition of multi-receptor tyrosine kinase pathwaysOrestis Lyros, Annett Mueller, Florian Heidel, et al.
World Journal of Gastroenterology|May 7, 2009
High miR-196a levels promote the oncogenic phenotype of colorectal cancer cellsCarl Christoph Schimanski, Kirsten Frerichs, Fareed Rahman, et al.
International Journal of Oncology|May 18, 2011
SNP rs1801157 significantly correlates with distant metastasis in CXCL12 expressing esophagogastric cancerCarl C Schimanski, Mareike Jordan, Friederike Schlaegel, et al.
Future Oncology (London, England)|December 2, 2020
MAHOGANY: margetuximab combination in HER2+ unresectable/metastatic gastric/gastroesophageal junction adenocarcinomaDaniel Vt Catenacci, Minori Rosales, Hyun Cheol Chung, et al.
Zeitschrift Fur Gastroenterologie|April 12, 2018
[ASCO- and ESMO-update 2017 - highlights of the 53. meeting of the American Society of Clinical Oncology/ASCO 2017 and European Society for Medical Oncology/ESMO congress 2017]Thomas J Ettrich, Matthias Ebert, Sylvie Lorenzen, et al.
World Journal of Gastroenterology|July 19, 2008
VEGF-D expression correlates with colorectal cancer aggressiveness and is downregulated by cetuximabMarkus Moehler, Christian Frings, Annett Mueller, et al.
Targeted Oncology|September 20, 2019
Immune Checkpoint Inhibitors as Switch or Continuation Maintenance Therapy in Solid Tumors: Rationale and Current StatePetros Grivas, Bradley J Monk, Daniel Petrylak, et al.
Pageof 22